Skip Navigation
Home |Multimedia

Podcasts

Health Care
June 11, 2019
Exposing the Myths of America's Dependence on China for Medicine (Guest: Rosemary Gibson) Podcast
Rosemary Gibson, senior advisor at The Hastings Center, a medical ethics think tank, joins the show to discuss her book "ChinaRX: Exposing the Myths of America's Dependence on China for Medicine."
Health Care
June 4, 2019
Legislator Confidential – The Forces Against Certificate of Need Repeal (Guests: Reps. Jason Chipman, Daniel Martin, and Cameron Sexton) Podcast
Three state lawmakers give frank thoughts on the difficulties they encountered trying to eliminate Certificate of Need laws in their states. They discuss lobbying, phantom projects, “sky is falling” alarmism, and how opponents actually make a case for ri
Health Care
May 28, 2019
One Way to Lower Drug Costs: Price Drugs by Indication (Guest: Roger Klein) Podcast
Rather than government mandated price controls on drugs, why not have drug companies base prices on indication? Roger D. Klein discusses “indication specific” drug prices and how this might lower prices and improve health outcomes.

All Podcasts

  • Date
  • Topic
Clear All Filters
View  10  |  20  |  40
Health Care
June 11, 2019
Exposing the Myths of America's Dependence on China for Medicine (Guest: Rosemary Gibson)
By Sarah Lee
Rosemary Gibson, senior advisor at The Hastings Center, a medical ethics think tank, joins the show to discuss her book "ChinaRX: Exposing the Myths of America's Dependence on China for Medicine."
Tags
June 4, 2019
Legislator Confidential – The Forces Against Certificate of Need Repeal (Guests: Reps. Jason Chipman, Daniel Martin, and Cameron Sexton)
By AnneMarie Schieber
Three state lawmakers give frank thoughts on the difficulties they encountered trying to eliminate Certificate of Need laws in their states. They discuss lobbying, phantom projects, “sky is falling” alarmism, and how opponents actually make a case for ri
Tags
May 28, 2019
One Way to Lower Drug Costs: Price Drugs by Indication (Guest: Roger Klein)
By AnneMarie Schieber
Rather than government mandated price controls on drugs, why not have drug companies base prices on indication? Roger D. Klein discusses “indication specific” drug prices and how this might lower prices and improve health outcomes.
Tags
May 23, 2019
Shaking up Medicare at CMS (Guest: Adam Boehler)
By Sarah Lee
Adam Boehler, a Trump administration appointee who runs the Center for Medicare and Medicaid Services' (CMS) Innovation Center, details a new voluntary payment model that moves Medicare primary care payments away from fee-for-service
Tags
May 20, 2019
How Doctors are Getting Help Setting up Independent Practices (Guest: Freedom Healthworks)
By AnneMarie Schieber
Direct primary care is taking off around the country, but how do doctors take the first step? Adam Habig, Christopher Habig and Dr. Rasheet Patel are the founders of Freedom Healthworks, a consulting firm that helps doctors do just that.
Tags
May 14, 2019
Talking Health Care with Rep. Dan Crenshaw
By Sarah Lee
Rep. Dan Crenshaw (R-TX) discusses policy currently being proposed in the halls of Congress, from the exorbitant costs associated with single payer plans like Medicare For All to a recent, smaller bill that would help with drug price transparency.
Tags
May 10, 2019
Democrats Attacking Health Care Reforms for Political Gain (Guest: Marie Fishpaw)
By Sarah Lee
Marie Fishpaw explains the Democrats' just-voted-on bill, HR 986. Fishpaw says is will undercut the Trump administration's effective regulatory relief efforts to the health care sector. Texas Republican Dan Crenshaw is a vocal critic of HR 986.
Tags
May 7, 2019
AOC and the VA (Guest: Dan Caldwell)
By Sarah Lee
The Heartland Institute's health care policy advisor Sarah Lee interviews Dan Caldwell on Rep. Alexandria Ocasio-Cortez's (AOC) twitter disagreement with Donald Trump on how well the Department of Veteran's Affairs administers health care to veterans.
Tags
May 2, 2019
Voices of Vapers: Fighting for Vaping in the Evergreen State (Guest: WA State Rep. Drew MacEwen)
By Lindsey Stroud
Washington State Representative Drew MacEwen joins the podcast to discuss legislation in the 2019 session, including T-21, taxes, and a bill that did include a flavor ban.
Tags
May 1, 2019
Understanding PBMs (Guest: Dr. Matthew Stryker)
By Sarah Lee, Matthew D. Stryker
Dr. Matthew Stryker, a doctor of pharmacy at Albany College of Pharmacy and Health Services, talks about his latest op-ed for Fox News entitled, "Who Profits From Drug Price Decreases?"
Tags